Home > Annual Financials > DIVIS LABORATORIES

DIVIS LABORATORIES Financial Statement Analysis
[BOM: 532488|NSE : DIVISLAB]

The Revenues of DIVIS LABORATORIES have increased by 19.31% YoY .
The Earnings Per Share (EPS) of DIVIS LABORATORIES has increased by 36.93 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

DIVIS LABORATORIES Last 5 Annual Financial Results
[BOM: 532488|NSE : DIVISLAB]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹9,360 Cr₹7,845 Cr₹7,767 Cr₹8,960 Cr₹6,969 Cr
Expenses ₹6,391 Cr₹5,639 Cr₹5,398 Cr₹5,079 Cr₹4,108 Cr
Operating Profit (Excl OI) ₹2,969 Cr₹2,206 Cr₹2,369 Cr₹3,881 Cr₹2,861 Cr
Other Income ₹352 Cr₹339 Cr₹345 Cr₹116 Cr₹63 Cr
Interest ₹3.00 Cr₹4.00 Cr₹2.00 Cr₹2.00 Cr₹2.10 Cr
Depreciation ₹402 Cr₹378 Cr₹343 Cr₹312 Cr₹256 Cr
Profit Before Tax ₹2,916 Cr₹2,163 Cr₹2,369 Cr₹3,684 Cr₹2,666 Cr
Profit After Tax ₹2,191 Cr₹1,600 Cr₹1,824 Cr₹2,960 Cr₹1,984 Cr
Consolidated Net Profit ₹2,191 Cr₹1,600 Cr₹1,824 Cr₹2,960 Cr₹1,984 Cr
Earnings Per Share (Rs)₹82.68₹60.38₹68.83₹111.53₹74.75
PAT Margin (%)23.2920.2823.3332.9428.38
ROE(%)15.3512.1514.8928.1623.90
ROCE(%)20.4516.4619.3635.0632.07
Total Debt/Equity(x)0.000.000.000.000.00

Key Financials

Market Cap : ₹ 175,725.2 Cr
Revenue (TTM) : ₹ 9,360.0 Cr
Net Profit(TTM) : ₹ 2,191.0 Cr
EPS (TTM) : ₹ 82.5
P/E (TTM) : 80.2

Industry Peers & Returns1W1M1Y
DIVIS LABORATORIES -1.1% 0.1% 45.6%
SUN PHARMACEUTICAL INDUSTRIES 0.4% 1.8% 4.5%
CIPLA 3.8% 1.2% -1.1%
TORRENT PHARMACEUTICALS 2.2% 11.7% 11.7%
DR REDDYS LABORATORIES 1.4% -3.3% -7.2%
MANKIND PHARMA -1.7% 13% 22.9%
ZYDUS LIFESCIENCES 0.7% -0.6% -17.7%
LUPIN 1.5% 1.3% 7%
AUROBINDO PHARMA -1.4% -0.1% -17.7%


DIVIS LABORATORIES Revenues
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

19.31 %

5 Yr CAGR

7.65 %

Years Revenues % Change
Mar2025 ₹9,360 Cr
19.31
Mar2024 ₹7,845 Cr
1.00
Mar2023 ₹7,767 Cr
-13.31
Mar2022 ₹8,960 Cr
28.56
Mar2021 ₹6,969 Cr -


DIVIS LABORATORIES Operating Profit
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

34.59 %

5 Yr CAGR

0.93 %

Years Operating Profit % Change
Mar2025 ₹2,969 Cr
34.59
Mar2024 ₹2,206 Cr
-6.88
Mar2023 ₹2,369 Cr
-38.96
Mar2022 ₹3,881 Cr
35.65
Mar2021 ₹2,861 Cr -

Operating Margins
Y-o-Y

12.80 %

5 Yr CAGR

-6.24 %

Years Operating Margin% % Change
Mar2025 31.72%
12.80
Mar2024 28.12%
-7.80
Mar2023 30.5%
-29.59
Mar2022 43.32%
5.53
Mar2021 41.05% -

DIVIS LABORATORIES Profit After Tax
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

36.94 %

5 Yr CAGR

2.51 %

Years Profit After Tax % Change
Mar2025 ₹2,191 Cr
36.94
Mar2024 ₹1,600 Cr
-12.28
Mar2023 ₹1,824 Cr
-38.39
Mar2022 ₹2,960 Cr
49.19
Mar2021 ₹1,984 Cr -

PAT Margins
Y-o-Y

14.84 %

5 Yr CAGR

-4.82 %

Years PAT Margin(%) % Change
Mar2025 23.29 %
14.84
Mar2024 20.28 %
-13.07
Mar2023 23.33 %
-29.17
Mar2022 32.94 %
16.07
Mar2021 28.38 % -

DIVIS LABORATORIES Earnings Per Share (EPS)
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

36.93 %

5 Yr CAGR

2.55 %

Years EPS % Change
Mar2025 ₹83
36.93
Mar2024 ₹60
-12.28
Mar2023 ₹69
-38.29
Mar2022 ₹112
49.20
Mar2021 ₹75 -

DIVIS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

24.24 %

5 Yr CAGR

-10.64 %

Years ROCE % Change
Mar2025 20.45%
24.24
Mar2024 16.46%
-14.98
Mar2023 19.36%
-44.78
Mar2022 35.06%
9.32
Mar2021 32.07% -

DIVIS LABORATORIES Share Price vs Sensex

Current Share Price : ₹6,618.7
Current MarketCap: ₹ 175,725.2 Cr
Updated EOD on :Jul 25,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-1.1%

0.1%

45.6%

SENSEX

-0.4%

-1.6%

1.3%

DIVIS LABORATORIES related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE LARGEMIDCAP 4.5% 7.2% 8.3%
BSE 500 SHARIAH 4.3% 4.3% 1.1%
BSE MOMENTUM INDEX 0.6% 0.3% -3.3%
BSE HEALTHCARE 0.5% 4% 17%
NSE Indices1W1M1Y
NIFTY HEALTHCARE INDEX 1.2% 4.1% 12.6%
NIFTY100 ALPHA 30 1% -0.8% -8.9%
NIFTY PHARMA 0.3% 3.9% 9.2%
NIFTY200 ALPHA 30 -0.1% -1.6% -8.6%
NIFTY100 ESG -0.3% -1% 0.6%

You may also like the below Video Courses


FAQ about DIVIS LABORATORIES Financials


How the annual revenues of DIVIS LABORATORIES have changed ?

The Revenues of DIVIS LABORATORIES have increased by 19.31% YoY .

How the Earnings per Share (EPS) of DIVIS LABORATORIES have changed?

The Earnings Per Share (EPS) of DIVIS LABORATORIES has increased by 36.93 % YoY .